Varenicline-d4

Varenicline-d4 Struktur
2183239-01-0
CAS-Nr.
2183239-01-0
Englisch Name:
Varenicline-d4
Synonyma:
Varenicline-d4;Varenicline Nitroso D4;7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline-7,7,9,9-d4
CBNumber:
CB02675994
Summenformel:
C13H13N3
Molgewicht:
211.27
MOL-Datei:
2183239-01-0.mol

Varenicline-d4 Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
Water: 0.0877 mg/mL
Aggregatzustand
A solid
Wasserlöslichkeit
Water: 0.0877 mg/mL

Sicherheit

Varenicline-d4 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Varenicline-d4 is intended for use as an internal standard for the quantification of varenicline by GC- or LC-MS. Varenicline is a full agonist of α7 subunit-containing neuronal nicotinic acetylcholine receptors (nAChRs; EC50 = 18 μM) and a partial agonist of α4β2 subunit-containing nAChRs (EC50 = 2.3 μM). Formulations containing varenicline have been used as aids in smoking cessation.

Varenicline-d4 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Varenicline-d4 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684
sales@rrkchem.com China 56057 58
Hefei Molake Biotechnology Co., Ltd. 0551-66336380 18956014586
983438788@qq.com China 2099 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11289 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18865 58
Shanghai isotope chemical co.,ltd 021-021-51600108 13062666369
sales@chinaisotope.com China 4274 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 8740 58
Nanjing Shizhou Biology Technology Co.,Ltd 17301488900
judy.xia@synzest.com China 12584 58

  • Varenicline-d4
  • 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline-7,7,9,9-d4
  • Varenicline Nitroso D4
  • 2183239-01-0
Copyright 2019 © ChemicalBook. All rights reserved